Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contraceptive
Marketing
FDA accuses Mayne of giving misleading impression of drug safety
The FDA alleged Mayne minimized the risks associated with Nextstellis and misrepresented how the drug compares to rival contraceptives.
Nick Paul Taylor
May 13, 2025 9:30am
Lupin recalls birth control pills deemed possibly ineffective
Aug 1, 2023 8:21am
Perrigo snags historic OTC nod for birth control tablet Opill
Jul 13, 2023 9:45am
Perrigo's OTC birth control pill aces FDA expert meeting
May 10, 2023 4:40pm
FDA raises questions about real-world use of OTC birth control
May 8, 2023 9:50am
Perrigo's OTC bid for contraceptive Opill secures May FDA adcomm
Mar 28, 2023 3:06pm
